Cellulite is architecture, not fat.

Extracorporeal shockwave — the pressure pulses used for kidney stones and tendons at lower energy — is thought to soften the fibrous septae, stimulate collagen and improve microcirculation. It has the best non-invasive evidence in the field. The CelluShock trial was single-centre, double-blind and sham-controlled: women with moderate-to-severe cellulite received six sessions of focused shockwave (2,000 impulses, 0.35 mJ/mm²) or sham every one to two weeks, both arms with a daily gluteal strength programme; the Cellulite Severity Scale fell from 10.9 to 8.3 in the active group at 12 weeks, a 2.53-point improvement, while the sham group went from 10.0 to 10.1 (sham-controlled shockwave trial). The 2015 meta-analysis found eleven clinical studies in 297 women, five of them randomised in 123, with both focused and radial devices effective over six to eight sessions (shockwave meta-analysis); an open-label Brazilian series of 12 sessions in 30 women reduced the severity score from 11.1 to 9.5, cut hip circumference by 3 cm and thinned the fat on MRI, with 89% satisfied (acoustic wave series). The registered 2025 systematic review of 24 randomised trials named it the "standout intervention", with a consistent 2.07-point cellulite reduction across four studies (2025 systematic review).

The tier is moderate rather than strong because the trials are small, follow-up is short, and the effect fades over months — a course a year is the usual maintenance. It is painless-to-uncomfortable, needs no anaesthetic, and is the sensible first clinic step for the lax and mild dimpled types; a deep tethered pit still needs the band cut. Check the device safety notes for anticoagulants and pregnancy.

Radiofrequency heats the dermis and the fat beneath it to provoke collagen contraction and remodelling, and its trials measure what it can do: tighten the envelope over the lobules for a while. The 2005 controlled study gave 20 women eight twice-weekly treatments of bipolar radiofrequency, infrared light and suction massage to one randomly chosen thigh and buttock, the other side untreated, with blinded quartile grading of photographs and circumference measurements to six months (combined RF device trial). The current generation pairs monopolar radiofrequency with targeted pressure energy: in 30 people (28 of them women) given four treatments over two to four weeks, cellulite severity improved from moderate to mild in 95%, with blinded evaluators reporting aesthetic improvement through six months — open-label, single-arm (RF plus pressure energy study). The 2025 systematic review found radiofrequency "exhibited a statistically significant reduction of thigh circumference" and of fat thickness across its randomised trials — the tape measure again, where shockwave had moved a severity score (systematic review).

The reason for the tier is durability: the pathophysiology reviews class heat-based results as "inconsistent or short-term" because they treat the dermis and fat, not the band (pathophysiology review). For the lax type it is the right tool for a season; for a tethered dimple it is a temporary softening. The sagging skin guide covers the devices and their body-contouring cousins in depth.

Ultrasound at the intensities used for face-lifting delivers a controlled thermal injury to the dermis, and the same remodelling that lifts a brow can tighten a thigh. In a prospective multicentre study, 65 women (mean age 46, all skin types) had two treatments; at three months the Cellulite Severity Scale improved by 1.61 units, 89.2% improved on the global scale, the laxity score improved by 0.70, and two blinded reviewers agreed in identifying the post-treatment photographs in 89.2% of pairs, with no device-related adverse events (parallel ultrasound study). A follow-on study of 60 subjects with a high-density handpiece reported similar blinded improvements in severity, aesthetic and laxity scales at three months (high-density handpiece study).

Two sessions instead of eight is the attraction; the missing control group and the three-month horizon are the reason for the tier. It belongs with the radiofrequency row as an envelope-tightener for the lax type, at a considerably higher price per session.

Rapid acoustic pulse technology fires pressure pulses at a rate designed to fracture the fibrous structures under the skin — a mechanical subcision without an incision. The pivotal trial treated 56 women with moderate-to-severe cellulite in one session with no anaesthesia; at 12 weeks the mean simplified Cellulite Severity Scale fell by 1.01 points, a 29.5% reduction, with global aesthetic improvement, participant satisfaction and a measured improvement in the laxity score (acoustic subcision pivotal trial). A retrospective analysis of 51 of those participants found at least two of three physicians correctly identifying the post-treatment photograph in 90% of sets and an 80.4% responder rate for laxity (laxity review).

A one-point drop is about half of what the vacuum-guided subcision achieved (2.1 points) on a similar 0–5 scale, with none of the bruising week; the trade-off is honest and the follow-up is short. It sits between the shockwave course and the surgical rows — for the woman with both dimples and laxity who wants a single, needle-free session and accepts a partial answer.

Injected carbon dioxide dilates local vessels and is claimed to break down fat and stimulate collagen. The pilot study gave ten women eight weekly sessions and reported a significant fall in cellulite degree from III to II, correlating with a reorganisation of the fat on ultrasound — ten women, no control (carboxytherapy pilot). The randomised comparison enrolled 48 women and gave six weekly sessions of carboxytherapy or phosphatidylcholine mesolipolysis: both groups improved significantly on a cellulite grading scale and thigh circumference at six months, with no difference between them — two active arms and no sham, so the shared improvement could be either treatment, the attention, or the season (carboxytherapy vs mesolipolysis trial).

The most rigorous randomised trials of carboxytherapy for cellulite are about how to make it hurt less — vibration anaesthesia and electrical currents during the injections (analgesia trial) — which tells you something about the sessions. Cheap, widely offered, and unproven against doing nothing.

Motorised rollers and suction were the first machines sold for cellulite and remain the commonest. The trial that tested Endermologie properly randomised 69 women (52 completed) to three groups, one of which had twice-weekly treatment of one thigh and buttock for 12 weeks with the other side as control, measuring body-mass index, girth at two points and fat depth by ultrasound, plus the surgeon's photographic assessment: "no statistical difference existed in measurements between legs for any of the treatment groups" (Endermologie trial). The low-level dual-wavelength laser-and-massage devices did better on their own endpoints — in 102 women with one thigh randomised to laser-massage and the other to massage alone, MRI showed the fat pad thinning on the laser side (laser-massage MRI trial), and in another study 83 women lost 0.64 cm of thigh circumference on the treated side against 0.20 cm on the untreated one (laser-massage study) — but those endpoints are fat and fluid, and a 0.4 cm difference in girth is not a dimple.

The systematic review of electrophysical agents found the "questionable methodological quality of many studies complicates the determination of effective treatments" (electrophysical agents review). Vacuum-electromagnetic combinations, "lipo-massage", cryo-wraps and the rest inherit that verdict until one of them runs a sham-controlled trial on a severity scale.

The device stabilises each dimple under vacuum in a small chamber, delivers local anaesthetic, and passes a microblade beneath the skin at a controlled depth of 6 or 10 mm to sever the band — subcision made reproducible. The pivotal study enrolled 55 women with moderate-to-severe cellulite for a single treatment: the mean score on a 0–5 version of the Cellulite Severity Scale, built from the number and depth of the dimples, fell from 3.4 to 1.3 at three months and 1.4 at one year, 47 subjects (93%) had at least a one-point improvement, satisfaction was 85% at three months and 94% at one year, and adverse events were transient and mild (pivotal subcision study). Forty-five of the women were followed to three years with blinded panel assessment of photographs, and the results supported the device's FDA clearance for "long-term reduction in the appearance of cellulite" (3-year follow-up). A retrospective Italian series treated 122 women and assessed 112 at twelve months: masked evaluators picked the pre-treatment image every time, every patient was satisfied, and the dimple score improved by at least one point, with larger effects at higher baseline grades and BMI (112-woman series).

The meta-analysis that compared subcision with the collagenase injection across 14 studies and 1,254 patients puts the cost in numbers: bruising in 99%, pain requiring analgesics in 60%, induration in 7%, skin discolouration in 7% — a fortnight of purple thighs for the most durable result in the field (subcision vs collagenase meta-analysis). The tier is moderate because every study is single-arm — no one has run a sham subcision — but the length and consistency of the follow-up is unmatched here. Candidates are the dimpled type on firm skin; the lax type can end up looser. Device availability varies by country and year; the technique — subcision through a small entry with a guided blade — is what to ask for.

Collagenase clostridium histolyticum dissolves collagen, and injected into a dimple it dissolves the band. It is the one cellulite treatment ever put through large, double-blind, placebo-controlled trials. In RELEASE-1 and RELEASE-2, 843 women with moderate-to-severe buttock cellulite received up to three sessions of 0.84 mg per area or placebo; at day 71 the primary endpoint — a two-level improvement on both the clinician- and patient-reported photonumeric scales — was met by 7.6% vs 1.9% and 5.6% vs 0.5%, and a one-level composite improvement by 37.1% vs 17.8% and 41.6% vs 11.2% (RELEASE-1 and -2). The pooled analysis put the odds of a two-level response at 5.9 times placebo (pooled analysis); the phase 2b trial in 375 women had reached 10.6% vs 1.6% and 44.6% vs 17.9% (phase 2b trial), and an open-label extension found the response durable in those who had achieved it (durability study).

Read those numbers twice. Against a real placebo, fewer than one woman in ten reached the two-level change the trial called success, and between one in nine and one in six placebo-injected women reached a one-level change on her own — the size of the expectation effect every uncontrolled study on this page is swimming in. The price was bruising in 89% and pain needing analgesics in 74%, with skin discolouration in 16% that could last months (meta-analysis of adverse events). The product was approved in the United States in 2020, never authorised in the EU, and its manufacturer announced in December 2022 that it would stop making and selling it. It stays on the page because it is the yardstick.

The laser approach treats all three components at once: a 1,440 nm fibre with a side-firing tip and a temperature-sensing cannula is passed subdermally under local anaesthetic to release the septae, reduce the herniating fat and heat the dermis to thicken it. The multicentre study treated 57 patients in a single three-step session; at six months blinded evaluators rated at least a one-point improvement in 96% of treated sites and picked the baseline from the post-treatment photograph in 95% of cases, with at least 90% of patients and physicians satisfied (57-patient study). At twelve months evaluators still identified 91% of baseline photographs, with mean improvement scores of 1.4 for dimples and 1.0 for contour irregularities (12-month results). A single-centre series of 24 women followed objective measures — elasticity, ultrasound dermal thickness, histology — for two years and found the benefit persisting in those who returned (24-month series).

It is more invasive than the blade devices — an operating-room procedure with a compression garment after — and, like them, has never been compared with a sham. The reviews rank it with subcision and shockwave as the modalities with "the most beneficial results" (2019 treatment review). The surgeon's experience with the temperature endpoints is the safety variable: too hot and the skin burns from beneath.

The refinement over the vacuum device is selectivity. A light-guided hook is passed under the skin from small entry points, the main ones in the gluteal crease (2.9 a woman on average in the pivotal study); tension on the skin makes each target dimple reappear, the septa responsible are identified by feel and then severed, and the surgeon confirms the dimple has released before moving on. The pilot study of ten women established feasibility with one incision in eight of them and no serious events (pilot study); the 20-woman multicentre study met its endpoint, a mean reduction of at least one point at 180 days, with a mean of 2.6: 18 of the 19 photographed (95%) improved by at least a point and all 19 were rated much or very much improved (20-woman study); the pivotal study treated 74 women aged 21–55 with a BMI under 30 at nine sites, with a mean Cellulite Severity Scale improvement of 1.5 points at 90 days and no device-related serious adverse events (pivotal study). A 2026 series combined it with helium-plasma radiofrequency to treat the laxity at the same session in 22 patients, with 77–82% improved at six months on imaging (combined series).

The logic — cut only the bands that are actually pulling — is the right one, and the early numbers match the older device's. The tier is emerging because the follow-up is months rather than years and the studies are the manufacturer's; the same bruising and the same patient selection apply.

Poly-L-lactic acid provokes new collagen over months wherever it is placed — the mechanism the collagen loss guide grades for the face — and a thicker, better-supported dermis over the lobules is exactly what the lax type lacks. The randomised, double-blind, placebo-controlled study enrolled 31 healthy women and gave each three treatments four weeks apart of subcision combined with either PLLA or saline injections into the buttocks or thighs; at three and six months the PLLA group showed statistically significant improvement on the global aesthetic scale rated by blinded investigators, on the Cellulite Severity Scale and on satisfaction, with tolerable treatments and no severe adverse events (PLLA vs saline trial). The 2026 study by Sculptra's maker injected it alone into the posterior thighs of women with grade 2–4 cellulite over one to three sessions: 28 of 29 (97%) improved on the global scale at nine months, with high satisfaction through twelve (PLLA thigh study).

Diluted calcium hydroxylapatite is the other biostimulator used the same way: three sessions by a cannula subcision technique cut the number of visible dimples by 54% at 14 weeks in 24 women, open-label (diluted CaHA study), and one session with microfocused ultrasound improved a 20-woman retrospective series by 4.5 points with new collagen on biopsy (ultrasound plus CaHA). Both are irreversible, both are off-label on the body unless the product's own label covers it (Lanluma, a CE-marked poly-L-lactic acid, lists the buttocks, thighs and cellulite; Sculptra's label is facial), and the nodule risk in the buttock is real — see Safety. Large areas need many vials; ask for the total before the first one.

Liposuction is the wrong tool for cellulite and has always been: it removes fat between the bands and leaves the tethers, and it thins the layer that hides the architecture. Post-liposuction skin irregularities are common enough that a 2024 paper proposed a definition and classification for them, noting "their similarities to cellulite" (post-liposuction irregularities). The evidence for treating them afterwards is a randomised comparison of shockwave and lymphatic drainage in 30 women with grade 3 cellulite after thigh liposuction, both with topical retinol (post-liposuction trial).

Fat grafting can fill a deep, isolated depression once the band has been released, and combined subdermal laser-plus-fat series exist from 2008 (laser and fat series); radiofrequency-assisted lipolysis, which heats and aspirates through a cannula, improved blinded severity scores in a ten-patient report by tightening the superficial fascial system (RFAL report). A case of fat embolism after liposuction combined with helium radiofrequency and cellulite subcision in one session is the reminder that stacking procedures multiplies their risks (fat embolism case). Contour surgery is a body-shape decision; the sagging skin guide covers when loose skin needs a lift rather than a device.